BTCC / BTCC Square / Global Cryptocurrency /
Klotho Neurosciences Stock Surges 175% on Lifespan Extension Breakthrough

Klotho Neurosciences Stock Surges 175% on Lifespan Extension Breakthrough

Global Cryptocurrency
Release Time:
2025-06-09 14:54:02
0

Klotho Neurosciences (KLTO) shares skyrocketed in pre-market trading after unveiling groundbreaking preclinical data. The biopharmaceutical firm's research suggests genetic overexpression of the α-KLOTHO gene could extend mammalian lifespan by 30-40%, based on murine studies.

The company secured exclusive worldwide rights to s-KL, a potential therapy targeting neurodegenerative and age-related conditions. This dual catalyst propelled KLTO stock to a 175.61% gain, though the equity remains down 96% year-over-year.

Articles on this site are sourced from public networks or curated by AI for informational purposes only and do not represent BTCC’s views. Original rights belong to the respective authors. For copyright concerns, please contact [email protected]. BTCC assumes no liability for the accuracy, timeliness, or completeness of this information, and disclaims all liability arising from reliance on such content. This content is for reference only and should not be taken as investment, legal, or commercial advice.

|Square

Get the BTCC app to start your crypto journey

Get started today Scan to join our 100M+ users